Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9600 posts found.

Steven Bates image

New drug pricing plans will ‘damage UK biotech’

August 16, 2013 Research and Development, Sales and Marketing BIA, Hunt, NHS, VBP, bates, biotech

The BioIndustry Association is warning that the government’s new drug pricing scheme could put future investment in the UK’s biotech …
News
laureen_debuono

Cadence appoints Laureen DeBuono to its Board

August 16, 2013 Manufacturing and Production, Medical Communications, Research and Development DeBuono, cadence

Biopharma firm Cadence Pharmaceuticals has appointed Laureen DeBuono to its Board of directors.  “We are very pleased to welcome Ms …
Appointment
claire_thom_astellas

Astellas hires senior VP from rival Takeda

August 15, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Takeda, oncology

Astellas has appointed Claire Thom from fellow Japanese firm Takeda to be senior vice president of its global oncology development. …
Appointment
Lilly image

Phoenix from the flames for Lilly cancer drug

August 14, 2013 Research and Development, Sales and Marketing NSCLC, lilly, lung cancer, necitumumab

A drug that once looked doomed to fail has shocked analysts by helping late-stage lung cancer patients live longer. Necitumumab …
News
anne_lindblad_emmes

New president and chief executive for EMMES

August 14, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMMES

Research support firm The EMMES Corporation has announced that its executive VP Dr Anne Lindblad has been promoted to president …
Appointment

The new NHS: a marriage of inconvenience?

August 13, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, NHS England, andy lee, market access, quarry house

As NHS England tries to squeeze more money out of the healthcare budget to pay for specialist commissioning, Andy Lee …
Feature
Vical image

Vical melanoma drug dropped

August 13, 2013 Research and Development, Sales and Marketing Vical, allovectin, melanoma

Vical has abandoned trials of a late-stage drug for the deadliest form of skin cancer after the treatment failed to …
News
hugh

Hugh McCafferty joins Pharmafocus editorial team

August 12, 2013 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, pharmafile

Appointment

Funding boost for UK health research projects

August 12, 2013 Medical Communications, Research and Development, Sales and Marketing Lord Howe, NIHR, UK government, funding boost

News
Malaria image

Sanaria’s malaria vaccine shows promise

August 9, 2013 Research and Development, Sales and Marketing PfSPZ, Vaccine, malaria, sanaria

Researchers in the US have announced promising results from a Phase I clinical trial of biotech firm Sanaria’s new malaria …
News
NICE image

AllTrials campaign releases manifesto

August 9, 2013 Medical Communications, Research and Development, Sales and Marketing Bad pharma, GSK, Goldacre, NICE, transparency

The UK clinical trial transparency initiative AllTrials has released its first detailed manifesto as it looks to ramp up pressure …
News

GSK banks on bioelectronics with new fund

August 9, 2013 Medical Communications, Research and Development, Sales and Marketing Bioelectronics, COPD, GSK, asthma, diabetes

GSK has established a $50 million venture capital fund to invest in the emerging field of bioelectronics. Described as one …
News
glen_campbell_bmj

BMJ appoints US managing director

August 9, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMJ, Campbell

Medical journal BMJ has hired Glen Campbell from Elsevier to be its US managing director. Campbell joins BMJ on 2 …
Appointment
Afinitor image

Late-stage failure for Afinitor

August 8, 2013 Research and Development, Sales and Marketing Afinitor, Cancer, Novartis, liver

Novartis’ oncology programme has received a blow with the news that Afinitor has failed to help patients live longer in …
News
Eylea image

Eylea trial boost in DME

August 7, 2013 Research and Development, Sales and Marketing Bayer, DME, Eylea, regenenron

The rival treatment to Novartis’ Lucentis has posted encouraging new study results in patients with diabetic macular oedema (DME). In …
News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026